Stock analysis on net
Export to Excel Export to OpenOffice.org Print

Johnson & Johnson (JNJ) | Enterprise Value to EBITDA (EV/EBITDA)

Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)

Johnson & Johnson, EBITDA calculation

USD $ in millions

Export to Excel Export to OpenOffice.org
  12 months ended Dec 30, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Net earnings attributable to Johnson & Johnson 10,853  9,672  13,334  12,266  12,949 
Net loss attributable to noncontrolling interest (339)
Interest expense, net of portion capitalized 532  571  455  451  435 
Income tax expense (benefit) 3,261  2,689  3,613  3,489  3,980 
Earnings before interest and tax (EBIT) 14,307  12,932  17,402  16,206  17,364 
Depreciation and amortization of property and intangibles 3,666  3,158  2,939  2,774  2,832 
Earnings before interest, tax, depreciation and amortization (EBITDA) 17,973  16,090  20,341  18,980  20,196 
Item Description The company
EBITDA To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. Johnson & Johnson's EBITDA declined from 2010 to 2011 but then slightly increased from 2011 to 2012.

EV to EBITDA Ratio, Current

Johnson & Johnson, current EV/EBITDA

Export to Excel Export to OpenOffice.org
  Johnson & Johnson Health Care
Selected Financial Data (USD $ in millions)
Enterprise value (EV) 241,092   
Earnings before interest, tax, depreciation and amortization (EBITDA) 17,973   
Ratio
EV/EBITDA 13.41 10.07

If company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.

Otherwise, if company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.

EV to EBITDA Ratio, Historical

Johnson & Johnson, EV/EBITDA calculation

Export to Excel Export to OpenOffice.org
    Dec 30, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
  Selected Financial Data (USD $ in millions)
Enterprise value (EV)1 208,219  166,071  152,243  169,561  150,194 
Earnings before interest, tax, depreciation and amortization (EBITDA)2 17,973  16,090  20,341  18,980  20,196 
  EV/EBITDA, Comparison to Industry
Johnson & Johnson3 11.59 10.32 7.48 8.93 7.44
  Industry, Health Care 9.28 7.90 8.16 7.35 7.02

2012 Calculations

3 EV/EBITDA = EV ÷ EBITDA
= 208,219 ÷ 17,973 = 11.59

Ratio Description The company
EV/EBITDA EV/EBITDA is a valuation indicator for the overall company rather than common stock. Johnson & Johnson's EV/EBITDA ratio increased from 2010 to 2011 and from 2011 to 2012.